These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8662813)

  • 1. Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5.
    Parker A; Clarke JB; Busby WH; Clemmons DR
    J Biol Chem; 1996 Jun; 271(23):13523-9. PubMed ID: 8662813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin.
    Arai T; Clarke J; Parker A; Busby W; Nam T; Clemmons DR
    J Biol Chem; 1996 Mar; 271(11):6099-106. PubMed ID: 8626396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I.
    Parker A; Rees C; Clarke J; Busby WH; Clemmons DR
    Mol Biol Cell; 1998 Sep; 9(9):2383-92. PubMed ID: 9725901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I.
    Bramani S; Song H; Beattie J; Tonner E; Flint DJ; Allan GJ
    J Mol Endocrinol; 1999 Aug; 23(1):117-23. PubMed ID: 10425523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I.
    Nam TJ; Busby W; Clemmons DR
    Endocrinology; 1997 Jul; 138(7):2972-8. PubMed ID: 9202242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth.
    Nam TJ; Busby WH; Rees C; Clemmons DR
    Endocrinology; 2000 Mar; 141(3):1100-6. PubMed ID: 10698186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions.
    Imai Y; Moralez A; Andag U; Clarke JB; Busby WH; Clemmons DR
    J Biol Chem; 2000 Jun; 275(24):18188-94. PubMed ID: 10766744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of insulin-like growth factor binding proteins in the control of IGF actions.
    Clemmons DR; Busby WH; Arai T; Nam TJ; Clarke JB; Jones JI; Ankrapp DK
    Prog Growth Factor Res; 1995; 6(2-4):357-66. PubMed ID: 8817679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation.
    Fowlkes JL; Thrailkill KM; George-Nascimento C; Rosenberg CK; Serra DM
    Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of IGFBP-5 binding to extracellular matrix and IGF-I-stimulated DNA synthesis by a peptide fragment of IGFBP-5.
    Rees C; Clemmons DR
    J Cell Biochem; 1998 Dec; 71(3):375-81. PubMed ID: 9831074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I.
    Jones JI; Gockerman A; Busby WH; Camacho-Hubner C; Clemmons DR
    J Cell Biol; 1993 May; 121(3):679-87. PubMed ID: 7683690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit.
    Schedlich LJ; Le Page SL; Firth SM; Briggs LJ; Jans DA; Baxter RC
    J Biol Chem; 2000 Aug; 275(31):23462-70. PubMed ID: 10811646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenesis of basic amino acids in the carboxyl-terminal region of insulin-like growth factor binding protein-5 affects acid-labile subunit binding.
    Firth SM; Clemmons DR; Baxter RC
    Endocrinology; 2001 May; 142(5):2147. PubMed ID: 11316783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
    Arai T; Busby W; Clemmons DR
    Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5.
    Yamaguchi Y; Yasuoka H; Stolz DB; Feghali-Bostwick CA
    J Cell Mol Med; 2011 Apr; 15(4):957-69. PubMed ID: 20345844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3.
    Firth SM; Ganeshprasad U; Baxter RC
    J Biol Chem; 1998 Jan; 273(5):2631-8. PubMed ID: 9446566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actions.
    Nam T; Moralez A; Clemmons D
    Endocrinology; 2002 Jan; 143(1):30-6. PubMed ID: 11751588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The carboxy-terminal domain of IGF-binding protein-5 inhibits heparin binding to a site in the central domain.
    Song H; Shand JH; Beattie J; Flint DJ; Allan GJ
    J Mol Endocrinol; 2001 Jun; 26(3):229-39. PubMed ID: 11357059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4.
    Chernausek SD; Smith CE; Duffin KL; Busby WH; Wright G; Clemmons DR
    J Biol Chem; 1995 May; 270(19):11377-82. PubMed ID: 7538115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells.
    Schedlich LJ; Young TF; Firth SM; Baxter RC
    J Biol Chem; 1998 Jul; 273(29):18347-52. PubMed ID: 9660801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.